Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Review Article

Literature-based Comparative Study between Herbal and Synthetic Mucolytics

Author(s): Pallabi Bhuyan, Tapash Chakraborty*, Rakib Ahmed, Nurul Ali and Shatabdi Ghose

Volume 19, Issue 4, 2023

Published on: 08 September, 2023

Page: [279 - 288] Pages: 10

DOI: 10.2174/1573398X19666230818142213

Price: $65

Abstract

Coughing and sneezing are the body’s reflexes to various acute and chronic respiratory illnesses like asthma, COPD, lung cancer, etc.

Mucus is a sticky, gelatinous material produced by the mucus gland to protect the airways. Mucolytics, antitussives and expectorants may help in treating hypersecretion of mucin that may lead to cough, cystic fibrosis, asthma, and COPD. Mucolytics if given along with the drugs like corticosteroids, albuterol sulphate, and levalbuterol HCl in asthma and for the management of COPD like corticosteroids and bronchodilators, may help in loosening the viscosity of the mucus and clearing it out.

Mucolytics can be synthetic or herbal in origin and work by one of the three processes, viz. enzymatic degradation, disulphide bond cleavage and calcium chelation. Mucolytics breaks down mucin structure and loosen the mucus, helping it to expel out from the body. Some examples of synthetic mucolytics are Bromhexine and N-acetylcysteine. Herbal mucolytics have traditionally been used for the treatment of cough by indigenous people of India. Malva sylvestris, Zizyphus vulgaris are some of the examples of herbal mucolytics.

« Previous Next »
Graphical Abstract

[1]
Henke MO, John G, Germann M, Lindemann H, Rubin BK. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am J Respir Crit Care Med 2007; 175(8): 816-21.
[http://dx.doi.org/10.1164/rccm.200607-1011OC] [PMID: 17255563]
[2]
Leal J, Smyth HDC, Ghosh D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharm 2017; 532(1): 555-72.
[http://dx.doi.org/10.1016/j.ijpharm.2017.09.018] [PMID: 28917986]
[3]
He J, Guo H, Zheng W, Yao W. Effects of stress on the mucus-microbial interactions in the gut. Curr Protein Pept Sci 2018; 20(2): 155-63.
[http://dx.doi.org/10.2174/1389203719666180514152406] [PMID: 29756575]
[4]
McShane A, Bath J, Jaramillo AM, et al. Mucus. Curr Biol 2021; 31(15): R938-45.
[http://dx.doi.org/10.1016/j.cub.2021.06.093] [PMID: 34375594]
[5]
Lang T, Hansson GC, Samuelsson T. Gel-forming mucins appeared early in metazoan evolution. Proc Natl Acad Sci 2007; 104(41): 16209-14.
[http://dx.doi.org/10.1073/pnas.0705984104] [PMID: 17911254]
[6]
Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem 1999; 274(45): 31751-4.
[http://dx.doi.org/10.1074/jbc.274.45.31751] [PMID: 10542193]
[7]
Hollingsworth MA, Swanson BJ. Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer 2004; 4(1): 45-60.
[http://dx.doi.org/10.1038/nrc1251] [PMID: 14681689]
[8]
Phillips TE, Phillips TH, Neutra MR. Regulation of intestinal goblet cell secretion. III. Isolated intestinal epithelium. Am J Physiol 1984; 247(6 Pt 1): G674-81.
[PMID: 6391203]
[9]
Jentoft N. Why are proteins O-glycosylated? Trends Biochem Sci 1990; 15(8): 291-4.
[http://dx.doi.org/10.1016/0968-0004(90)90014-3] [PMID: 2204153]
[10]
Dohrman A, Miyata S, Gallup M, et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta Mol Basis Dis 1998; 1406(3): 251-9.
[http://dx.doi.org/10.1016/S0925-4439(98)00010-6] [PMID: 9630659]
[11]
Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007; 52(9): 1176-93.
[PMID: 17716385]
[12]
Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173(5): 475-82.
[http://dx.doi.org/10.1164/rccm.200505-840OE] [PMID: 16126935]
[13]
Callaghan Rose M, Brown CF, Jacoby JZ III, Lynn WS, Kaufman B. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals. Pediatr Res 1987; 22(5): 545-51.
[http://dx.doi.org/10.1203/00006450-198711000-00015] [PMID: 3684381]
[14]
Sjåheim T, Kongerud J, Bjørtuft O, Drabløs PA, Malterud D, Halstensen TS. Reduced bronchial CD4+ T-cell density in smokers with occupational asthma. Eur Respir J 2006; 28(6): 1138-44.
[http://dx.doi.org/10.1183/09031936.06.00032906] [PMID: 16899487]
[15]
Juergens LJ, Worth H, Juergens UR, Juergens R, Juergens LJ, Worth H. New perspectives for mucolytic, anti-inflammatory and adjunctive therapy with 1,8-Cineole in COPD and Asthma: Review on the new therapeutic approach. Adv Ther 2020; 37(5): 1737-53.
[http://dx.doi.org/10.1007/s12325-020-01279-0] [PMID: 32200535]
[16]
Finkbeiner WE. Physiology and pathology of tracheobronchial glands. Respir Physiol 1999; 118(2-3): 77-83.
[http://dx.doi.org/10.1016/S0034-5687(99)00080-8]
[17]
Poole PJ. Role of mucolytics in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006; 1(2): 123-8.
[http://dx.doi.org/10.2147/copd.2006.1.2.123] [PMID: 18046889]
[18]
Hanisch FG, Müller S. MUC1: The polymorphic appearance of a human mucin. Glycobiology 2000; 10(5): 439-49.
[http://dx.doi.org/10.1093/glycob/10.5.439] [PMID: 10764832]
[19]
Argüeso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci 2002; 43(4): 1004-11.
[PMID: 11923240]
[20]
Aaron SD. Mucolytics for COPD: Negotiating a slippery slope towards proof of efficacy. Eur Respir J 2017; 50(4): 1701465.
[http://dx.doi.org/10.1183/13993003.01465-2017] [PMID: 29025882]
[21]
Rubin BK. Mucolytics, expectorants, and mucokinetic medications. Respir Care 2007; 52(7): 859-65.
[PMID: 17594730]
[22]
Laube BL, Auci RM, Shields DE, et al. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 1996; 153(2): 752-60.
[http://dx.doi.org/10.1164/ajrccm.153.2.8564129] [PMID: 8564129]
[23]
Konishi T, Shimada Y, Nagao T, Okabe H, Konoshima T. Antiproliferative sesquiterpene lactones from the roots of Inula helenium. Biol Pharm Bull 2002; 25(10): 1370-2.
[http://dx.doi.org/10.1248/bpb.25.1370] [PMID: 12392098]
[24]
Carvalho ACB, Lana TN, Perfeito JPS, Silveira D. The Brazilian market of herbal medicinal products and the impacts of the new legislation on traditional medicines. J Ethnopharmacol 2018; 212: 29-35.
[http://dx.doi.org/10.1016/j.jep.2017.09.040] [PMID: 28987598]
[25]
Kuang Y, Li B, Fan J, Qiao X, Ye M. Antitussive and expectorant activities of licorice and its major compounds. Bioorg Med Chem 2018; 26(1): 278-84.
[http://dx.doi.org/10.1016/j.bmc.2017.11.046] [PMID: 29224994]
[26]
Chakraborty R, De B, Devanna N, Sen S. Antitussive, expectorant activity of Marsilea minuta L., an Indian vegetable. J Adv Pharm Technol Res 2013; 4(1): 61-4.
[http://dx.doi.org/10.4103/2231-4040.107502] [PMID: 23662283]
[27]
Jr N, George S, Sagna A. Herbal expectorants for the pandemic period and beyond: A review. Nat Ayurvedic Med 2020; 4(3): 000254.
[28]
Siddiqui S, Faizi S. Studies in the chemical constituents of the fresh berries of solanum xanthocarpum schrad. and wendle. J Chem Soc Pak 2011; 5(4): 99.
[29]
Haq F, Ahmad H, Alam M. Traditional uses of medicinal plants of Nandiar Khuwarr catchment (District Battagram), Pakistan. J Med Plants Res 2011; 5(1): 39-48.
[30]
George S. Traditional uses of medicinal plants of NandiarKhuwarr catchment. Pakistan: District Battagram 2020; pp. 1-11.
[31]
Chakraborty A, Brantner AH. Study of alkaloids from Adhatoda vasica Nees on their antiinflammatory activity. Phytother Res 2001; 15(6): 532-4.
[http://dx.doi.org/10.1002/ptr.737] [PMID: 11536385]
[32]
Haq F. The ethno botanical uses of medicinal plants of Allai Valley, Western Himalaya Pakistan. Int J Plant Res 2012; 2(1): 21-34.
[http://dx.doi.org/10.5923/j.plant.20120201.04]
[33]
Prakash Sharma I, Kanta C, Chandra Semwal S, Goswami N. Wild fruits of Uttarakhand (India): Ethnobotanical and medicinal uses. Int J Complement Altern Med 2017; 8(3): 00260.
[34]
Tiwari P, Gond P, Koshale S, Prachi TC. Phytochemical analysis of different parts of Achyranthes Aspera. ~ 60 ~. J Pharmacogn Phytochem 2018; 2: 60-2.
[35]
Kokate CK, Gokhale MSB, Gokhale AS. Cultivation of Medicinal Plants. (5th ed. 2007.), 2015.
[36]
Rajani M, Soni S, Anandjiwala S, Patel G. Validation of different methods of preparation of <i> Adhatoda vasica</i> leaf juice by quantifi-cation of total alkaloids and vasicine. Indian J Pharm Sci 2008; 70(1): 36-42.
[http://dx.doi.org/10.4103/0250-474X.40329] [PMID: 20390078]
[37]
Mandolfino F, Frascio M, Perotti S, Lazzara F, Imperatore M, Bruno S. Diabetes mellitus and upper gut motility. Journal of Biological Research-Bollettino della Società Italiana di Biologia Sperimentale 2013; 86(1)
[38]
Asha S, Thirunavukkarasu P, World AMS. Phytochemical screening of Euphorbia hirta linn leaf extracts. World J Pharm Sci 2015; 3(6): 1104-12.
[39]
Soudahmini E, Senthil GM, Panayappan L, Divakar MC. Herbal remedies of Madugga tribes of Siruvani forest, South India. CSIR 2005.
[40]
Goraya K, Iqbal Z, Sajid MS, Muhammad G, Ain Q, Saleem M. Diversity of flora used for the cure of equine diseases in selected peri-urban areas of Punjab, Pakistan. J Ethnobiol Ethnomed 2013; 9(1): 70.
[http://dx.doi.org/10.1186/1746-4269-9-70] [PMID: 24283263]
[41]
Ohrnberger D. The bamboos of the world: Annotated nomenclature and literature of the species and the higher and lower taxa. In: The Bamboos of the World. 1st ed. 1999.
[42]
Erdem Y, Gisho H, Ekrem S, Mamoru T, Katsumi G, Yasumasa I. Traditional medicine in Turkey IV. Folk medicine in the Mediterranean subdivision. J Ethnopharmacol 1993; 39(1): 31-8.
[http://dx.doi.org/10.1016/0378-8741(93)90048-A] [PMID: 8331960]
[43]
Bai Y, Xia B, Xie W, et al. Phytochemistry and pharmacological activities of the genus Prunella. Food Chem 2016; 204: 483-96.
[http://dx.doi.org/10.1016/j.foodchem.2016.02.047] [PMID: 26988527]
[44]
Brandão MGL, Zanetti NNS, Oliveira P, Grael CFF, Santos ACP, Monte-Mór RLM. Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia. J Ethnopharmacol 2008; 120(2): 141-8.
[http://dx.doi.org/10.1016/j.jep.2008.08.004] [PMID: 18762237]
[45]
Thirupathi K, Kumar SS, Raju VS, Ravikumar B, Krishna DR, Mohan GK. A review of medicinal plants of the genus <I>Cordia</I>: their chemistry and pharmacological uses. J Nat Rem 2008; 1-10.
[46]
Bibi Y, Iqbal M, Hussain M, Laraib S, Tahir N, Safdar I. Overview of Dioscorea deltoidea Wall. Ex Griseb: An endangered medicinal plant from Himalaya region. J Biodivers Environ Sci 2016; 9(6): 2222-3045.
[47]
Dangwal LR, Chauhan AS. Dioscorea deltoidea Wall. ex Griseb. a highly threatened Himalayan medicinal plant: an overview. Int J Pharma Bio Sci 2015; 6(1)
[48]
Al-douri NA. A survey of medicinal plants and their traditional uses in Iraq. Pharm Biol 2011; 38(1): 74-9.
[49]
Physico-chemical and preliminary phytochemical study of seeds of datisca cannabina Linn (Datiscaceae) from himalaya region in Paki-stan. Pharm Regul Aff 2019; 8(1): 1-4.
[50]
Yue-xian W, Tun-yu J, Han L. Antitussive and expectorant properties of growing and fallen leaves of loquat (Eriobotrya japonica). Rev bras farmacogn 2018; 28(2): 239-42.
[51]
Hamada A, Yoshioka S, Takuma D, et al. The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats. Biol Pharm Bull 2004; 27(12): 1961-4.
[http://dx.doi.org/10.1248/bpb.27.1961] [PMID: 15577213]
[52]
Briggs CJ. Major herbs of ayurveda. Complement Ther Med 2003; 11(4): 276.
[http://dx.doi.org/10.1016/S0965-2299(03)00111-0]
[53]
Dennis VCA. TYLER’S HERBS OF CHOICE: the therapeutic use of phytomedicinals. (3rd ed.), CRC Press 2019.
[54]
Chitale PK. A comparative study of ayurveda and treatment by Indian drugs. Indian Books Centre 1997.
[55]
Gupta R. Yastimadhu (Glycyrrhiza glabra) - An important plant of Ayurvedic system of medicine. JMPS 2016; 4(4): 30-1.
[56]
Sen S, Chakraborty R, De B, Devanna N. An ethnobotanical survey of medicinal plants used by ethnic people in West and South district of Tripura, India. J For Res 2011; 22(3): 417-26.
[http://dx.doi.org/10.1007/s11676-011-0184-6]
[57]
Parihar P, Parihar L, Bohra A. In vitro antibacterial activity of fronds (leaves) of some important pteridophytes. J Microbiol Antimicrob 2010; 2(2): 19-22.
[58]
Dapaah G, Koffuor GA, Mante PK, Ben IO. Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand. Res Pharm Sci 2016; 11(2): 100-12.
[PMID: 27168749]
[59]
Ugulu I, Baslar S, Yorek N, Dogan Y. The investigation and quantitative ethnobotanical evaluation of medicinal plants used around Izmir province, Turkey. J Med Plants Res 2009; 3(5): 345-67.
[60]
Pandith SA, Dar RA, Lattoo SK, Shah MA, Reshi ZA. Rheum australe, an endangered high-value medicinal herb of North Western Himalayas: a review of its botany, ethnomedical uses, phytochemistry and pharmacology. Phytochem Rev 2018; 17(3): 573-609.
[http://dx.doi.org/10.1007/s11101-018-9551-7] [PMID: 32214920]
[61]
Kaloo ZA. Effect of growth regulators on the in vitro multiplication of Viola odorata. J Med Plant Res 2015; 2(4): 187-9.
[62]
Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354(3): 241-50.
[http://dx.doi.org/10.1056/NEJMoa043891] [PMID: 16421365]
[63]
Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354(3): 229-40.
[http://dx.doi.org/10.1056/NEJMoa043900] [PMID: 16421364]
[64]
Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2001; (2): CD002996.
[PMID: 11406058]
[65]
Sisson JH, Yonkers AJ, Waldman RH. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers. Chest 1995; 107(3): 747-51.
[http://dx.doi.org/10.1378/chest.107.3.747] [PMID: 7874947]
[66]
Albrecht HH, Dicpinigaitis PV, Guenin EP. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidiscip Respir Med 2017; 12(1): 31.
[http://dx.doi.org/10.1186/s40248-017-0113-4]
[67]
Hirsch SR, Viernes PF, Kory RC. The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis. A controlled in vitro and in vivo study. Chest 1973; 63(1): 9-14.
[http://dx.doi.org/10.1378/chest.63.1.9] [PMID: 4567445]
[68]
Olivier KN, Bennett WD, Hohneker KW, Zeman KL, Edwards LJ, Boucher RC. Acute safety, and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate +/- amiloride in normal human adults. Am J Respir Crit Care Med 2012; 154(1): 217-23.
[69]
Kellerman D, Rossi Mospan A, Engels J, Schaberg A, Gorden J, Smiley L. Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3. Pulm Pharmacol Ther 2008; 21(4): 600-7.
[http://dx.doi.org/10.1016/j.pupt.2007.12.003] [PMID: 18276176]
[70]
Gross NJ. Anticholinergic agents in COPD. Chest 1987; 91(S5): 52S-7S.
[http://dx.doi.org/10.1378/chest.91.5_Supplement.52S] [PMID: 3552471]
[71]
Ramnarine SI, Haddad EB, Khawaja AM, Mak JC, Rogers DF. On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 1996; 494(2): 577-86.
[http://dx.doi.org/10.1113/jphysiol.1996.sp021515] [PMID: 8842014]
[72]
Ishihara H, Shimura S, Satoh M, et al. Muscarinic receptor subtypes in feline tracheal submucosal gland secretion. Am J Physiol 1992; 262(2 Pt 1): L223-8.
[PMID: 1539678]
[73]
Agnew JE, Bateman JR, Pavia D, Clarke SW. Peripheral airways mucus clearance in stable asthma is improved by oral corticosteroid therapy. Bull Eur Physiopathol Respir 1984; 20(3): 295-301.
[PMID: 6743872]
[74]
Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125(S2): 52S-61S.
[http://dx.doi.org/10.1378/chest.125.2_suppl.52S] [PMID: 14872001]
[75]
Seemungal TAR, Wilkinson TMA, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 178(11): 1139-47.
[http://dx.doi.org/10.1164/rccm.200801-145OC] [PMID: 18723437]
[76]
Crosbie PAJ, Woodhead MA. Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 2009; 33(1): 171-81.
[http://dx.doi.org/10.1183/09031936.00042208] [PMID: 19118228]
[77]
Daviskas E, Anderson SD, Eberl S, Chan H-K, Young IH, Seale JP. Effects of terbutaline in combination with mannitol on mucociliary clearance. Eur Respir J 2002; 20(6): 1423-9.
[http://dx.doi.org/10.1183/09031936.02.00301502] [PMID: 12503699]
[78]
Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 1993; 103(3): 805-11.
[http://dx.doi.org/10.1378/chest.103.3.805] [PMID: 8095449]
[79]
Delavoie F, Molinari M, Milliot M, et al. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells. Am J Respir Cell Mol Biol 2009; 40(4): 388-97.
[http://dx.doi.org/10.1165/rcmb.2008-0037OC] [PMID: 18931328]
[80]
Germouty J, Jirou-Najou JL. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration 1987; 51(S1): 37-41.
[81]
Malerba M, Ragnoli B. Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opin Drug Metab Toxicol 2008; 4(8): 1119-29.
[http://dx.doi.org/10.1517/17425255.4.8.1119] [PMID: 18680446]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy